By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Edge Therapeutics 

NJIT-EDC Biotechnology Incubator
139 South Street, Suite 102
New Providence  New Jersey  07974  U.S.A.
Phone: 800-208-EDGE Fax: 800-208-3433



Company News
Edge Therapeutics Reports Second Quarter Financial Results And Recent Highlights 8/3/2016 10:21:38 AM
Edge Therapeutics Announces Closing Of $20 Million Debt Facility With Hercules Capital 8/2/2016 8:34:54 AM
Edge Therapeutics Announces First Patient Treated In Phase III NEWTON 2 Study Of EG-1962 In Adult Patients With Aneurysmal Subarachnoid Hemorrhage 7/29/2016 8:12:17 AM
Edge Therapeutics To Host Conference Call On August 3, 2016 To Discuss Second Quarter Financial Results 7/27/2016 8:20:18 AM
Edge Therapeutics To Participate In Guggenheim Securities 3rd Annual Healthcare Conference 12/8/2015 7:38:13 AM
Edge Therapeutics Names W. Bradford Middlekauff As Senior Vice President, General Counsel And Secretary 11/5/2015 9:58:49 AM
Edge Therapeutics Announces Closing Of Initial Public Offering And Full Exercise Of Over-Allotment Option 10/7/2015 10:00:26 AM
Edge Therapeutics Reports Positive Top-Line Phase I/II NEWTON Trial Results Of EG-1962 In Aneurysmal Subarachnoid Hemorrhage 8/19/2015 8:12:46 AM
Edge Therapeutics Files for $115 Million 8/18/2015 7:49:13 AM
Edge Therapeutics’ Chief Executive Officer Brian Leuthner Receives EY Entrepreneur Of The Year 2015 New Jersey Region Award 6/29/2015 12:48:17 PM